Wells and Enteric Disease Transmission: A randomized trial of children supplied drinking water from private wells (WET-Trial)
水井和肠道疾病传播:一项针对儿童从私人水井提供饮用水的随机试验(WET-试验)
基本信息
- 批准号:10199991
- 负责人:
- 金额:$ 78.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdenovirusesAdvisory CommitteesAgeBacteriaCampylobacterCanadaChildChildhoodCommunitiesConsumptionCryptosporidiumDataDevicesDiarrheagenic E. coliDiseaseElderlyEnteralEnterovirusEpidemiologic MethodsFecesGiardiaHealthHealth Care CostsHouseholdImmuneImmunocompromised HostIncidenceInterventionKnowledgeLinkModelingNorovirusPaperPennsylvaniaPlacebosPoliciesPrivatizationProtozoaPublishingRandomized Controlled TrialsRiskRisk AssessmentRisk EstimateSalmonellaSchoolsShigellaSourceSystemTestingUltraviolet RaysUnited StatesViralVirusVulnerable PopulationsWashingtonWaterWater SupplyWater consumptionWisconsinWorkburden of illnesscostdisease transmissiondrinking waterenteric infectionenteric pathogenepidemiologic datagastrointestinalground waterhigh riskmicrobialpathogenplacebo grouprandomized trialrural familiesstool samplewater qualitywater samplingwater treatmentwaterborne illnesswaterborne pathogenwell water
项目摘要
Approximately 48 million people in the US are served by private, and frequently untreated, wells. Our best
estimate is that 1.3 million cases of gastrointestinal illnesses (GI) per year are attributed to consuming
water from untreated private wells in the US, but in reality, there are no robust epidemiological data that can
be used to estimate cases of GI attributable to these sources. It is likely that well water-associated GI causes
significant healthcare costs and lost work/school days, as well as increased risk for long term health
complications. This impact is magnified when accounting for vulnerable populations such as children under the
age of 5, the elderly, and the immunocompromised.
We propose the first randomized controlled trial (RCT) to estimate the burden of GI associated with
private well water. We will test if household treatment of private well water by ultraviolet light (UV) vs.
sham (placebo inactive UV device) decreases the incidence of GI in children under 5. At present, there
are no prior RCTs or studies that have sought causal links between GI and the consumption of untreated water
from private wells despite the fact that pathogens have been recovered in groundwater, including deep
aquifers.
Under the guidance of an interdisciplinary advisory committee we will execute the following aims:
Aim 1- Quantify the incidence rate of endemic childhood GI associated with consuming untreated private well
water and compare that to the incidence rate of consuming well water treated by UV.
Aim 1a- Construct a Quantitative Microbial Risk Assessment (QMRA) using water quality data we collect to
estimate the risk of childhood GI associated with consuming untreated private well water and compare the
incidence from the risk model to the incidence we calculate in Aim 1.
Aim 2- Identify, quantify and compare viral, bacterial and protozoan pathogens in stool of children consuming
UV treated or untreated (sham) private well water (including both asymptomatic and symptomatic cases).
Aim 3- Explore the presence of pathogens in untreated well water and stool samples of children consuming
untreated private well water (sham group only).
These data will fill a knowledge gap on sporadic GI associated with federally-unregulated private water
supplies in the US. Our results will test an affordable water treatment intervention and inform GI burden
estimates and policy decisions for managing well water in the US and globally. Policy changes will help better
protect rural families, especially children who are at highest risk for sporadic enteric infections.
在美国,大约有4800万人使用私人的、经常未经处理的威尔斯井。我们最好的
据估计,每年有130万例胃肠道疾病(GI)归因于消费
美国未经处理的私人威尔斯井中的水,但实际上,没有可靠的流行病学数据可以
用于估计可归因于这些来源的GI病例。很可能与井水相关的GI导致
医疗保健费用高昂,工作/上学时间减少,长期健康风险增加
并发症如果考虑到弱势群体,如儿童,
5岁,老年人和免疫功能低下者。
我们提出了第一个随机对照试验(RCT),以估计胃肠道的负担与
私人井水我们将测试家庭处理私人井水的紫外线(UV)与。
假手术(安慰剂无活性紫外线装置)降低了5岁以下儿童胃肠道的发生率。而目前
没有先前的随机对照试验或研究寻找GI和饮用未经处理的水之间的因果关系
从私人威尔斯井中提取的病原体,
含水层
在跨学科咨询委员会的指导下,我们将实现以下目标:
目标1-量化与饮用未经处理的私人水井相关的地方性儿童胃肠道发病率
并将其与饮用经紫外线处理的井水的发病率进行比较。
目标1a-利用我们收集的水质数据构建定量微生物风险评估(QMRA),
估计与饮用未经处理的私人井水相关的儿童GI风险,并比较
从风险模型的发生率到我们在目标1中计算的发生率。
目的2-确定、量化和比较儿童粪便中的病毒、细菌和原生动物病原体,
紫外线处理或未经处理(假)私人井水(包括无症状和有症状的病例)。
目的3-探索未经处理的井水和儿童粪便样本中是否存在病原体,
未经处理的私人井水(仅假手术组)。
这些数据将填补与联邦政府不受管制的私人水有关的零星GI的知识空白
在美国的供应。我们的研究结果将测试负担得起的水处理干预措施,并告知GI负担
为美国和全球的井水管理提供评估和政策决策。政策变化将有助于更好地
保护农村家庭,特别是最易患散发性肠道感染的儿童。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heather M Murphy其他文献
The effects of racism, social exclusion, and discrimination on achieving universal safe water and sanitation in high-income countries
种族主义、社会排斥和歧视对高收入国家实现全民安全用水和卫生设施的影响
- DOI:
10.1016/s2214-109x(23)00006-2 - 发表时间:
2023-04-01 - 期刊:
- 影响因子:18.000
- 作者:
Joe Brown;Charisma S Acey;Carmen Anthonj;Dani J Barrington;Cara D Beal;Drew Capone;Oliver Cumming;Kristi Pullen Fedinick;Jacqueline MacDonald Gibson;Brittany Hicks;Michal Kozubik;Nikoleta Lakatosova;Karl G Linden;Nancy G Love;Kaitlin J Mattos;Heather M Murphy;Inga T Winkler - 通讯作者:
Inga T Winkler
Heather M Murphy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heather M Murphy', 18)}}的其他基金
Wells and Enteric Disease Transmission: A randomized trial of children supplied drinking water from private wells (WET-Trial)
水井和肠道疾病传播:一项针对儿童从私人水井提供饮用水的随机试验(WET-试验)
- 批准号:
10030794 - 财政年份:2020
- 资助金额:
$ 78.32万 - 项目类别:
Wells and Enteric Disease Transmission: A randomized trial of children supplied drinking water from private wells (WET-Trial)
水井和肠道疾病传播:一项针对儿童从私人水井提供饮用水的随机试验(WET-试验)
- 批准号:
10468665 - 财政年份:2020
- 资助金额:
$ 78.32万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 78.32万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 78.32万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 78.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 78.32万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 78.32万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 78.32万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 78.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 78.32万 - 项目类别:
Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 78.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 78.32万 - 项目类别:
Studentship